By Sriparna Roy (Reuters) -Akero Therapeutics shares gained 106% before the bell on Monday, after its lead drug showed it can ...

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...

Mefenamic acid, a common anti-inflammatory drug already approved for pain management, has been found to significantly reduce ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Patients with metabolic dysfunction-associated steotohepatitis (MASH) who are already taking a glucagon-like peptide-1 ...

A study by DKFZ researchers shows that inhibiting the enzyme aldolase A in glycolysis traps energy in liver cancer cells, ...

Discover how tirzepatide, a diabetes drug, offers hope for congenital generalized lipodystrophy (CGL) treatment, potentially ...

GATC West Virginia played a role in a groundbreaking AI-powered analysis of a new cancer drug in development — an analysis that saved inestimable hours and dollars for the client. \Calif.-based GATC ...

GV Research Platform (GVRP), a leading provider of preclinical research solutions, has announced a strategic partnership with ...

Fatty liver disease, or hepatic steatosis, occurs when excess fat accumulates in liver cells. Commonly associated with ...

A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.